Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations (Parenthetical)

v3.23.4
Consolidated Statements of Operations (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Research and Development Expense [Member]    
Share-Based Payment Arrangement, Expense $ 2,037 $ 3,635
General and Administrative Expense [Member]    
Share-Based Payment Arrangement, Expense $ 2,698 $ 3,117